Clinical Trial Update: INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) [Phase 2]

View source ↗

Summary

INSIGhT is a Phase 2 clinical trial investigating individualized screening of innovative therapies for glioblastoma; recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Patrick Wen, MD | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING